Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiogenesis Inhibition in Oncology”

101 trials

Showing 20 of 101 results

Testing effectiveness (Phase 2)Study completedNCT01006369
What this trial is testing

Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Rutgers, The State University of New Jersey 38
Testing effectiveness (Phase 2)Study completedNCT00389441
What this trial is testing

Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
Pfizer 52
Early research (Phase 1)Study completedNCT00454649
What this trial is testing

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

Who this might be right for
Neoplasms
Pfizer 102
Post-approval studies (Phase 4)Study completedNCT02497118
What this trial is testing

Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)UnknownNCT02748772
What this trial is testing

Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical

Who this might be right for
Colorectal Neoplasms
The First People's Hospital of Hefei 148
Testing effectiveness (Phase 2)Study completedNCT00083408
What this trial is testing

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

Who this might be right for
Multiple Myeloma
University of Arkansas 20
Large-scale testing (Phase 3)Study completedNCT00334282
What this trial is testing

Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 435
Testing effectiveness (Phase 2)Study completedNCT00094055
What this trial is testing

Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
Pfizer 60
Testing effectiveness (Phase 2)Looking for participantsNCT06878625
What this trial is testing

A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer

Who this might be right for
Evaluating the Efficacy of Trop-2 ADC Combination Therapy in Advanced Triple-Negative Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 138
Large-scale testing (Phase 3)Not Yet RecruitingNCT07134218
What this trial is testing

Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Changhai Hospital 180
Not applicableUnknownNCT00518557
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis

Who this might be right for
Hepatocellular Carcinoma
Southeast University, China 60
Testing effectiveness (Phase 2)Study completedNCT01227928
What this trial is testing

Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women

Who this might be right for
Neoplasms, Ovarian
GlaxoSmithKline 145
Large-scale testing (Phase 3)UnknownNCT03048877
What this trial is testing

Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Peking Union Medical College Hospital 118
Early research (Phase 1)Study completedNCT00322400
What this trial is testing

Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer

Who this might be right for
Locally Recurrent and Metastatic Breast Cancer
Amgen 46
Early research (Phase 1)Study completedNCT00722293
What this trial is testing

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 111
Early research (Phase 1)Study completedNCT00129337
What this trial is testing

Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Tumors
Peregrine Pharmaceuticals 28
Testing effectiveness (Phase 2)Study completedNCT00367679
What this trial is testing

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerLung Cancer, Non-Small Cell
GlaxoSmithKline 35
Early research (Phase 1)Study completedNCT00033215
What this trial is testing

S-3304 in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Shionogi 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07320963
What this trial is testing

Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 52
Testing effectiveness (Phase 2)Study completedNCT00094094
What this trial is testing

Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung NeoplasmsCarcinoma, Non-small Cell Lung
Pfizer 32
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation